Sangamo Therapeutics Inc (SGMO) — Capital Reinvestment Ratio
Latest as of September 2024:
0.01x
Sangamo Therapeutics Inc (SGMO) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow ($11.76 Million) in capital expenditures ($115.00K). See Sangamo Therapeutics Inc (SGMO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$11.76 Million
USD
Capital Expenditures
$115.00K
USD
Data as of
Sep 2024
Most recent filing
Sangamo Therapeutics Inc Capital Reinvestment Ratio (2017–2020)
This chart tracks Sangamo Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Sangamo Therapeutics Inc (2017–2020)
Year-by-year Capital Reinvestment Ratio for Sangamo Therapeutics Inc from 2017 to 2020. For live market cap and broader valuation context, see Sangamo Therapeutics Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.09x | $169.88 Million | $14.71 Million | ▼ -92.5% |
| 2018 | 1.16x | $37.15 Million | $43.06 Million | ▲ +245.5% |
| 2017 | 0.34x | $11.18 Million | $3.75 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow